When comparing NACT-treated samples with untreated ones in cancer patients the expression of TMEM51, NOTCH1, EEPD1, MAFB, and HLA-DRB5 remained increased in monocytes of treated patients (Figure 2B). The gene discussed is HLA-DRB5; the disease is cancer.